PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injury

Laboratory Investigation

Volumn 80, Issue 5, 2000, Pages 697-707

  Kinnman, Nils ^a,b,c   Hultcrantz, Rolf ^c   Barbu, Véronique ^a   Rey, Colette ^a   Wendum, Dominique ^b   Poupon, Raoul ^a,b   Housset, Chantal ^a,b  

^a INSERM   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; ENDOTHELIN 1; PLATELET DERIVED GROWTH FACTOR; PROTEIN TYROSINE KINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT; CELL MIGRATION; CELL STIMULATION; CELLULAR DISTRIBUTION; CHEMOTAXIS; CHOLESTASIS; CONTROLLED STUDY; EPITHELIUM CELL; LIVER INJURY; MALE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STELLATE CELL;

EID: 0034086195     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780073     Document Type: Article

References (43)

1. Abdel-Aziz G, Rescan P-Y, Clément B, Lebeau G, Rissel M, Grimaud J-A, Campion J-P, and Guillouzo A (1991). Cellular sources of matrix proteins in experimentally induced cholestatic rat liver. J Pathol 164:167-174.
2. Buchdunger E, Zimmermann J, Mett H, Meyer T, Muller M, Druker BJ, and Lydon NB (1996). Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res 56:100-104.
3. Carloni V, Romanelli RG, Pinzani M, Laffi G, and Gentilini P (1997). Focal adhesion kinase and phospholipase Cγ involvement in adhesion and migration of human hepatic stellate cells. Gastroenterology 112:522-531.
4. Clozel M, Breu V, Gray GA, Kalina B, Löffler B-M, Burri K, Cassai J-M, Hirth G, Müller M, Neidhart W, and Ramuz H (1994). Pharmacological characterization of bosentan, a new potent orally active nonpeptide receptor antagonist. J Pharmacol Exp Ther 270:228-235.
5. Desmet V, Roskams T, and Van Eyken P (1995). Ductular reaction in the liver. Pathol Res Pract 191:513-524.
6. Friedman SL (1993). The cellular basis of hepatic fibrosis. N Engl J Med 328:1828-1835.
7. Friedman SL, and Arthur MJP (1989). Activation of rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of proliferation via induction of platelet-derived growth factor receptors. J Clin Invest 84:1780-1785.
8. Friedman S, and Roll F (1987). Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation and stractan. Anal Biochem 161:207-218.
9. Grappone C, Pinzani M, Parola M, Pellegrini G, Caligiuri A, DeFranco R, Marra F, Herbst H, Alpini G, and Milani S (1999). Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats. J Hepatol 31:100-109.
10. Grinko I, Geerts A, and Wisse E (1995). Experimental biliary fibrosis correlates with increased numbers of fat-storing and Kupffer cells, and portal endotoxemia. J Hepatol 23:449-458.
11. Hardonk MJ, and Atmosoerodjo-Briggs J (1992). Evidence for the anatomical connection between the space of Disse and the portal tract in human and rat liver. In: Knook DL and Wisse E, editors. Cells of the hepatic sinusoid: Proceedings of the Sixth International Kupffer Cell Symposium. Antwerp: The Kupffer Cell Foundation, 182-184.
12. Hart CE, Forstrom JW, Kelly JD, Seifert RA, Smith RA, Ross R, Murray MJ, and Bowen-Pope DF (1988). Two classes of PDGF receptor recognize different isoforms of PDGF. Science 240:1529-1531.
13. Hecker KH, and Roux KH (1996). High and low annealing temperatures increase both specificity and yield in touch-down and stepdown PCR. Biotechniques 20:478-485.
14. Heldin CH, Backstrom G, Ostman A, Hammacher A, Ronnstrand L, Rubin K, Nister M, and Westermark B (1988). Binding of different dimeric forms of PDGF to human fibroblasts: Evidence for two separate receptor types. Embo J 7:1387-1393.
15. Herren B, Weyer KA, Rouge M, Lotscher P, and Pech M (1993). Conservation in sequence and affinity of human and rodent PDGF ligands and receptors. Biochim Biophys Acta 1173:294-302.
16. Hines JE, Johnson SJ, and Burt AD (1993). In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury. Am J Pathol 142:511-518.
17. Housset C, Carayon A, Housset B, Legendre C, Hannoun L, and Poupon R (1993a). Endothelin-1 secretion by human gallbladder epithelial cells in primary culture. Lab Invest 69:750-755.
18. Housset C, Rockey DC, and Bissell DM (1993b). Endothelin receptors in rat liver: Lipocytes as a contractile target for endothelin-1. Proc Natl Acad Sci USA 90:9266-9270.
19. Hultcrantz R, Mengarelli S, and Strandvik B (1986). Morphological findings in the liver of children with cystic fibrosis: A light and electron microscopical study. Hepatology 6:881-889.
20. Ikeda K, Wakahara T, Wang YQ, Kadoya H, Kawada N, and Kaneda K (1999). In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation. Hepatology 29:1760-1767.
21. Kountouras J, Billing BH, and Scheuer PJ (1984). Prolonged bile duct obstruction: A new experimental model for cirrhosis in the rat. Br J Exp Pathol 65:305-311.
22. Krause AW, Carley WW, and Webb WW (1984). Fluorescent erythrosin B is preferable to tryptan blue as a vital exclusion dye for mammalian cells in monolayer culture. J Histochem Cytochem 32:1084-1090.
23. Lindblad A, Hultcrantz R, and Strandvik B (1992). Bile-duct destruction and collagen deposition: A prominent ultrastructural feature of the liver in cystic fibrosis. Hepatology 16:372-381.
24. Maher J, and McGuire R (1990). Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest 86:1641-1648.
25. Malizia G, Brunt EM, Peters MG, Rizzo A, Broekelmann TJ, and McDonald JA (1995). Growth factor and procollagen type I gene expression in human liver disease. Gastroenterology 108:145-156.
26. Mallat A, Fouassier L, Préaux AM, Serradeil-Le Gal C, Raufaste D, Rosenbaum J, Dhumeaux D, Jouneaux C, Mavier P, and Lotersztajn S (1995). Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. J Clin Invest 96:42-49.
27. Marra F, Gentilini A, Pinzani M, Choudhury GG, Parola M, Herbst H, Dianzani MU, Laffi G, Abboud HE, and Gentilini P (1997). Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells. Gastroenterology 112:1297-1306.
28. Marra F, Romanelli RG, Giannini C, Failli P, Pastacaldi S, Arrighi MC, Pinzani M, Laffi G, Montalto P, and Gentilini P (1999). Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology 29:140-148.
29. Mennone A, Alvaro D, Cho W, and Boyer JL (1995). Isolation of small polarized bile duct units. Proc Natl Acad Sci USA 92:6527-6531.
30. Narayanan R, Lawlor KG, Schaapveld RQJ, Cho KR, Vogelstein B, Tran PB-V, Osborne MP, and Telang NT (1992). Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-1 fibroblasts. Oncogene 7:553-561.
31. Peacock AJ, Dawes KE, Shock A, Gray AJ, Reeves JT, and Laurent GJ (1992). Endothelin-1 and endothelin-3 induce chemotaxis and replication of pulmonary fibroblasts. Am J Respir Cell Mol Biol 7:492-499.
32. Pinzani M, Gesualdo L, Sabbah GM, and Abboud HE (1989). Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 84:1786-1793.
33. Pinzani M, Milani S, De Franco R, Grappone C, Caligiuri A, Gentilini A, Tosti-Guerra C, Maggi M, Failli P, Ruocco C, and Gentilini P (1996a). Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 110:534-548.
34. Pinzani M, Milani S, Herbst H, DeFranco R, Grappone C, Gentilini A, Caligiuri A, Pellegrini G, Vinh Ngo D, Romanelli RG, and Gentilini P (1996b). Expression of Platelet-Derived Growth Factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am J Pathol 148:785-800.
35. Poo J-L, Jiménez W, Munoz RM, Bosch-Marcé M, Bordas N, Morales-Ruiz M, Pérez M, Deulofeu R, Solé M, Arroyo V, and Rodés J (1999). Chronic blockade of endothelin receptors in cirrhotic rats: Hepatic and hemodynamic effects. Gastroenterology 116:161-167.
36. Rockey DC, and Chung JJ (1996). Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing. J Clin Invest 98:1381-1388.
37. Rockey DC, Fouassier L, Chung JJ, Carayon A, Vallée P, Rey C, and Housset C (1998). Cellular localization of endothelin-1 and increased production in liver injury in the rat: Potential for autocrine and paracrine effects on stellate cells. Hepatology 27:472-480.
38. Rutenberg AM, Hwakyo K, Fischbein JW, Hanker JS, Wasserkrug HL, and Seligman AM (1968). Histochemical and ultrastructural demonstration of γ-glutamyl transpeptidase activity. J Histochem Cytochem 17:517-526.
39. Seglen PO (1976). Preparation of isolated rat liver cells. Methods Cell Biol 13:29-83.
40. Tang L, Tanaka Y, Marumo F, and Sato C (1994). Phenotypic change in portal fibroblasts in biliary fibrosis. Liver 14:76-82.
41. Tuchweber B, Desmoulière A, Bochaton-Piallat M-L, Rubbia-Brandt L, and Gabbiani G (1996). Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab Invest 74:265-278.
42. Vassbotn FS, Östman A, Siegbahn A, Holmsen H, and Heldin C-H (1992). Neomycin is a platelet-derived growth factor (PDGF) antagonist that allows discrimination of PDGF α-and β-receptor signals in cells expressing both receptor types. J Biol Chem 267:15635-15641.
43. Wong L, Yamasaki G, Johnson RJ, and Friedman SL (1994). Induction of β-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest 94:1563-1569.